Clinical trialNCT04626791RecruitingPhase 2Interventional

Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma

SponsorAcademic and Community Cancer Research UnitedEnrollment45Mantle Cell Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Stephen D Smith
Academic and Community Cancer Research United
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ochsner Nci Community Oncology Research Program
New Orleans, Louisiana, United States
Withdrawn
Metropolitan-Mount Sinai Medical Center
Minneapolis, Minnesota, United States
Withdrawn
Mount Sinai Hospital
New York, New York, United States
Active, not recruiting
Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
Steven I. Park
Recruiting
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Withdrawn
University of Washington Medical Center - Montlake
Seattle, Washington, United States
Stephen D. Smith
Recruiting
Aurora Cancer Care-Milwaukee West
Wauwatosa, Wisconsin, United States
Withdrawn

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 3 Aug 2021
Primary completion: 3 Aug 2024
Completion: 3 Aug 2028
Last update posted: 12 Mar 2024
Registered enrollment: 45
Registry id: NCT04626791

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.